Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study. [electronic resource]
Producer: 20110927Description: 121-7 p. digitalISSN:- 2146-8427
- Adolescent
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Basiliximab
- Comorbidity
- Contraindications
- Cost-Benefit Analysis
- Diabetes Mellitus -- economics
- Female
- Graft Rejection -- epidemiology
- Humans
- Hyperlipidemias -- economics
- Hypertension -- economics
- Immunosuppression Therapy -- economics
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Kidney Transplantation -- immunology
- Living Donors
- Male
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Prospective Studies
- Recombinant Fusion Proteins -- therapeutic use
- Steroids -- adverse effects
- Tacrolimus -- therapeutic use
- Transplantation, Homologous
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.